Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.

Bressa GM, Marini S, Gregori S.

Int J Clin Pharmacol Res. 1987;7(2):111-9.

PMID:
3108171
2.

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam.

Ceulemans DL, Hoppenbrouwers ML, Gelders YG, Reyntjens AJ.

Pharmacopsychiatry. 1985 Sep;18(5):303-5.

PMID:
3931107
3.

5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.

Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N.

Acta Psychiatr Scand. 1991 Apr;83(4):244-8.

PMID:
1903019
4.

Effects of ritanserin on sleep disturbances of dysthymic patients.

Paiva T, Arriaga F, Wauquier A, Lara E, Largo R, Leitao JN.

Psychopharmacology (Berl). 1988;96(3):395-9.

PMID:
3146774
5.

5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo.

Bersani G, Grispini A, Marini S, Pasini A, Valducci M, Ciani N.

Clin Neuropharmacol. 1990 Dec;13(6):500-6.

PMID:
2125857
6.

Ritanserin versus lorazepam: a double-blind, cross-over study of reaction times in healthy volunteers.

Altamura AC, Colacurcio F, Marini S.

Int J Clin Pharmacol Res. 1989;9(3):197-201.

PMID:
2568349
7.

Serotonin-influencing drugs in the treatment of panic disorder.

Westenberg HG, den Boer JA.

Psychopathology. 1989;22 Suppl 1:68-77.

PMID:
2498967
8.

[Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].

Botte L, Bienfait J, Dethier J, Even P, Evrard JL, Fraipont J, Goffin L, Willemse P.

Acta Psychiatr Belg. 1981 Nov-Dec;81(6):595-608. French.

PMID:
6125089
9.

Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.

Laakmann G, Schüle C, Lorkowski G, Baghai T, Kuhn K, Ehrentraut S.

Psychopharmacology (Berl). 1998 Apr;136(4):357-66.

PMID:
9600581
11.
12.
13.

[Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].

Danion JM, Brion S, Escande M, Ropert R, Sacquepee L, Singer L, Scotto JC.

Encephale. 1984;10(3):135-8. French.

PMID:
6389091
14.

A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.

Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.

J Clin Psychopharmacol. 1993 Dec;13(6):429-37.

PMID:
7907097
15.

[Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].

Lemoine P, Touchon J, Billardon M.

Encephale. 1997 Jul-Aug;23(4):290-9. French.

PMID:
9417395
16.

Safety evaluation of ritanserin--an investigational serotonin antagonist.

Barone JA, Bierman RH, Cornish JW, Hsuan A, Drake ND, Colaizzi JL.

Drug Intell Clin Pharm. 1986 Oct;20(10):770-5.

PMID:
3095082
17.

Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.

Grünberger J, Saletu B, Linzmayer L, Böck G, Weissgram S, Brandstaätter N, Frey R, Saletu-Zyhlarz G.

Methods Find Exp Clin Pharmacol. 1997 Nov;19(9):645-54.

PMID:
9500129
19.

Evidence for serotonin-S2 receptor involvement in analgesia in humans.

Sandrini G, Alfonsi E, De Rysky C, Marini S, Facchinetti F, Nappi G.

Eur J Pharmacol. 1986 Nov 4;130(3):311-4.

PMID:
3098573
20.

A double-blind study of alprazolam and lorazepam in the treatment of anxiety.

Ruiz AT.

J Clin Psychiatry. 1983 Feb;44(2):60-2.

PMID:
6131066

Supplemental Content

Support Center